IPCA Laboratories Limited(IN:IPCALAB)
₹1,866.75-18.45 (-0.98%)
IN:IPCALAB
IPCA Laboratories Limited financials statements
₹1,866.75
At close:-18.45 (-0.98%)
Want to see IN:IPCALAB full AI Analyst Report?
IPCA Laboratories Limited (IPCALAB) Financial Statements
2 Followers
IPCA Laboratories Limited Financial Overview
IPCA Laboratories Limited's market cap is currently ₹473.52B. The company's EPS TTM is ₹44.98; its P/E ratio is 33.75; and it has a dividend yield of 0.32%. IPCA Laboratories Limited has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 96.46B | ₹ 89.41B | ₹ 77.06B | ₹ 62.48B | ₹ 58.30B |
| Gross Profit | ₹ 61.83B | ₹ 58.60B | ₹ 48.58B | ₹ 37.25B | ₹ 36.23B |
| Operating Income | ₹ 23.32B | ₹ 36.66B | ₹ 29.61B | ₹ 22.65B | ₹ 22.90B |
| EBITDA | ₹ 19.62B | ₹ 16.95B | ₹ 12.89B | ₹ 9.65B | ₹ 12.91B |
| Net Income | ₹ 11.41B | ₹ 7.38B | ₹ 5.47B | ₹ 4.71B | ₹ 8.84B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 11.98B | ₹ 11.08B | ₹ 8.45B | ₹ 21.79B | ₹ 13.59B |
| Total Assets | ₹ 123.70B | ₹ 117.61B | ₹ 111.01B | ₹ 86.26B | ₹ 76.24B |
| Total Debt | ₹ 8.09B | ₹ 13.63B | ₹ 14.38B | ₹ 14.81B | ₹ 8.07B |
| Net Debt | ₹ 2.44B | ₹ 10.19B | ₹ 12.29B | ₹ 2.23B | ₹ 5.32B |
| Total Liabilities | ₹ 28.46B | ₹ 33.72B | ₹ 33.74B | ₹ 27.11B | ₹ 20.82B |
| Stockholders' Equity | ₹ 80.64B | ₹ 69.48B | ₹ 63.32B | ₹ 58.42B | ₹ 54.92B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 4.86B | ₹ 5.00B | ₹ 5.33B | ₹ 3.11B | ₹ 3.77B |
| Operating Cash Flow | ₹ 11.42B | ₹ 12.75B | ₹ 9.45B | ₹ 8.06B | ₹ 8.56B |
| Investing Cash Flow | ₹ -2.47B | ₹ -8.94B | ₹ -12.92B | ₹ -7.25B | ₹ -8.55B |
| Financing Cash Flow | ₹ -7.54B | ₹ -2.13B | ₹ -5.53B | ₹ 5.07B | ₹ 4.27B |
Currency in INR

